» Articles » PMID: 32733879

Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression

Overview
Specialty Cell Biology
Date 2020 Aug 1
PMID 32733879
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Glioma is a fatal brain tumor characterized by rapid proliferation and treatment resistance. Ferroptosis is a newly discovered programmed cell death and plays a crucial role in the occurrence and progression of tumors. In this study, we identified ferroptosis specific markers to reveal the relationship between ferroptosis-related genes and glioma by analyzing whole transcriptome data from Chinese Glioma Genome Atlas, The Cancer Genome Atlas dataset, GSE16011 dataset, and the Repository of Molecular Brain Neoplasia Data dataset. Nineteen ferroptosis-related genes with clinical and pathological features of glioma were identified as highly correlated. Functional assays in glioma cell lines indicated the association of ferroptosis with temozolomide resistance, autophagy, and glioma cell migration. Therefore, the identified ferroptosis-related genes were significantly correlated with glioma progression.

Citing Articles

Nanomaterials Enhanced Sonodynamic Therapy for Multiple Tumor Treatment.

Yang M, Wang X, Peng M, Wang F, Hou S, Xing R Nanomicro Lett. 2025; 17(1):157.

PMID: 39992547 PMC: 11850698. DOI: 10.1007/s40820-025-01666-8.


Tight junction proteins in glial tumors development and progression.

Moskal J, Michalak S Front Cell Neurosci. 2025; 19:1541885.

PMID: 39963115 PMC: 11830821. DOI: 10.3389/fncel.2025.1541885.


Ferroptosis-Related Transcriptional Level Changes and the Role of CIRBP in Glioblastoma Cells Ferroptosis.

Yang Z, Zhang T, Zhu X, Zhang X Biomedicines. 2025; 13(1).

PMID: 39857625 PMC: 11761263. DOI: 10.3390/biomedicines13010041.


Exploring the role of Disulfidptosis in glioma progression: insights into tumor heterogeneity and therapeutic potential through single-cell RNA sequencing.

Fan X, Chen M Discov Oncol. 2024; 15(1):829.

PMID: 39714742 PMC: 11666858. DOI: 10.1007/s12672-024-01685-8.


Endothelial cell ferroptosis influences IDH wild-type glioblastoma growth in recurrent glioblastoma multiforme patients.

Liang B, Ding X, Yang S, Feng E Braz J Med Biol Res. 2024; 57:e13961.

PMID: 38985083 PMC: 11249198. DOI: 10.1590/1414-431X2024e13961.


References
1.
Liang C, Zhang X, Yang M, Dong X . Recent Progress in Ferroptosis Inducers for Cancer Therapy. Adv Mater. 2019; 31(51):e1904197. DOI: 10.1002/adma.201904197. View

2.
Ji Q, Aoyama C, Nien Y, Liu P, Chen P, Chang L . Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Cancer Res. 2004; 64(20):7610-7. DOI: 10.1158/0008-5472.CAN-04-1608. View

3.
Sato M, Kusumi R, Hamashima S, Kobayashi S, Sasaki S, Komiyama Y . The ferroptosis inducer erastin irreversibly inhibits system x- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells. Sci Rep. 2018; 8(1):968. PMC: 5772355. DOI: 10.1038/s41598-018-19213-4. View

4.
Junttila M, Evan G . p53--a Jack of all trades but master of none. Nat Rev Cancer. 2009; 9(11):821-9. DOI: 10.1038/nrc2728. View

5.
Liu H, Schreiber S, Stockwell B . Targeting Dependency on the GPX4 Lipid Peroxide Repair Pathway for Cancer Therapy. Biochemistry. 2018; 57(14):2059-2060. PMC: 5962875. DOI: 10.1021/acs.biochem.8b00307. View